Breastfeeding May Lower Risk Of Ovarian Cancer: Study

The findings of new research suggest breastfeeding a baby, even for a short period of time, may reduce a woman’s risk of getting ovarian cancer.

While breast feeding for longer periods of time reduced a woman’s risk of ovarian cancer by up to 34%, even three months or less of breastfeeding reduced the risk by about 18%, according to findings published this month in the medical journal JAMA Oncology.

Researchers from Harvard Medical School analyzed data on nearly 10,000 women with ovarian cancer, and compared them to 14,000 control subjects participating in the Ovarian Cancer Association Consortium from November 1989 to December 2009.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The study involved questionnaires and interviews to collect data on the women’s breastfeeding history, including duration per child breastfed, age at first and last breastfeeding, and years since last breastfeeding.

According to the findings, breastfeeding was associated with a 24% reduced risk of invasive epithelial ovarian cancer. Longer breastfeeding duration and shorter time since the last breastfeeding episode were linked with a further decrease in risk.

The researchers determined that breastfeeding for one to three months was associated with an 18% decreased breast cancer risk, while breastfeeding for 12 or more months was linked to a 34% lower risk.

Having breastfed more recently was associated with a reduction in risk that lasted for decades. However, researchers determined having breastfed at all led to a benefit lasting for at least 30 days.

Compared to women who never breastfed, breastfeeding was linked to a 44% reduced risk of ovarian cancer. Having breastfed at all in the last 30 years decreased a woman’s risk by 17%.

More than 200,000 women in the United States are diagnosed with ovarian cancer every year, according to the American Cancer Society. Women who are diagnosed often have a poor prognosis. About 45% of women diagnosed with ovarian cancer survive at least five years after diagnosis.

While the relationship between breastfeeding and ovarian cancer is unclear, and the study does not prove a causal link, it does indicate an association between breastfeeding and a reduced risk of ovarian cancer, the researchers determined.

“This large study with extensive information on breastfeeding provides epidemiological evidence that breastfeeding, a potentially modifiable factor, may confer significant reduction in ovarian cancer risk, including high-grade serous, the deadliest subtype,” the researchers wrote.


  • OLApril 9, 2020 at 3:47 am

    This was the information I knew in 1971 to convince my wife to nurse our firstborn.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.